Newer Therapies: Dual agonists like Tirzepatide also show high efficacy and safety in fasting populations
The Zepbound (tirzepatide) label recommends switching to a non-oral birth control method, or adding a barrier method, for 4 weeks after starting Zepbound and for 4 weeks after each dose increase
That dual mechanism is part of why we see such meaningful results in clinical trials, with patients losing up to about 21 percent of their body weight when combined with lifestyle changes. While often associated with weight loss, Zepbound may also support better blood sugar, cholesterol and blood pressure levels, and it can even help manage conditions like fatty liver and sleep apnea, says Dr
These drugs, based on the GLP-1 hormone, seem to be everywhere at the moment helping people control their diabetes and lose weight, and offering hope that they might also reduce the risk of cardiovascular disease or even, one day, treat drug and alcohol addiction
The endogenous ligand was finally identified in 1999 by Kojima and colleagues: ghrelin, a 28-amino-acid peptide produced mainly by the stomach